Skip to content
2000
Volume 12, Issue 9
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Flora Tang started biotech consulting on drug discovery operation and technology in 2007. Flora has extensive pharmaceutical experiences working at Amgen as Director of Research; SUGEN (subsidiary of Pharmacia) as Director of Discovery Technology; Eli Lilly; and GlaxoSmithKline. The scope of her work experiences involves high throughput biology using cutting-edge technologies and managing business operations. Flora started applying high content screening to drug discovery process soon after the inception of HCS.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/138620709789383295
2009-11-01
2025-04-10
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/138620709789383295
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test